Literature DB >> 22750986

Inhibition of HIV-1 Integrase gene expression by 10-23 DNAzyme.

Nirpendra Singh1, Atul Ranjan, Souvik Sur, Ramesh Chandra, Vibha Tandon.   

Abstract

HIV Integrase (IN) is an enzyme that is responsible for the integration of the proviral genome into the human genome, and this integration step is the first step of the virus hijacking the human cell machinery for its propagation and replication. 10-23 DNAzyme has the potential to suppress gene expressions through sequence-specific mRNA cleavage. We have designed three novel DNAzymes, DIN54, DIN116, and DIN152, against HIV-1 Integrase gene using Mfold software and evaluated them for target site cleavage activity on the in vitro transcribed mRNA. All DNAzymes were tested for its inhibition of expression of HIV Integrase protein in the transiently transfected cell lines. DIN116 and DIN152 inhibited IN-EGFP expression by 80 percent and 70 percent respectively.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22750986     DOI: 10.1007/s12038-012-9216-4

Source DB:  PubMed          Journal:  J Biosci        ISSN: 0250-5991            Impact factor:   1.826


  41 in total

Review 1.  Prospects for antiviral ribozymes and deoxyribozymes.

Authors:  Alessio Peracchi
Journal:  Rev Med Virol       Date:  2004 Jan-Feb       Impact factor: 6.989

2.  Inhibition of EGFP expression by siRNA in EGFP-stably expressing Huh-7 cells.

Authors:  Mingmei Cao; Hao Ren; Xin Pan; Wei Pan; Zhong-Tian Qi
Journal:  J Virol Methods       Date:  2004-08       Impact factor: 2.014

3.  Breaking up is easy to do (if you're a DNA enzyme that cleaves RNA).

Authors:  Scott K Silverman
Journal:  Chem Biol       Date:  2004-01

4.  Potent inhibition of HIV-1 gene expression and TAT-mediated apoptosis in human T cells by novel mono- and multitarget anti-TAT/Rev/Env ribozymes and a general purpose RNA-cleaving DNA-enzyme.

Authors:  Hoshang Unwalla; Samitabh Chakraborti; Vikas Sood; Nidhi Gupta; Akhil C Banerjea
Journal:  Antiviral Res       Date:  2006-06-08       Impact factor: 5.970

5.  Identification of Id4 as a regulator of BRCA1 expression by using a ribozyme-library-based inverse genomics approach.

Authors:  C Beger; L N Pierce; M Kruger; E G Marcusson; J M Robbins; P Welcsh; P J Welch; K Welte; M C King; J R Barber; F Wong-Staal
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-02       Impact factor: 11.205

6.  A DNA enzyme that cleaves RNA.

Authors:  R R Breaker; G F Joyce
Journal:  Chem Biol       Date:  1994-12

7.  In situ demonstration of inhibitory effects of hammerhead ribozymes that are targeted to the hepatitis Bx sequence in cultured cells.

Authors:  M Passman; M Weinberg; M Kew; P Arbuthnot
Journal:  Biochem Biophys Res Commun       Date:  2000-02-24       Impact factor: 3.575

8.  Design of antisense oligonucleotides stabilized by locked nucleic acids.

Authors:  Jens Kurreck; Eliza Wyszko; Clemens Gillen; Volker A Erdmann
Journal:  Nucleic Acids Res       Date:  2002-05-01       Impact factor: 16.971

9.  Inhibition of human breast carcinoma proliferation, migration, chemoinvasion and solid tumour growth by DNAzymes targeting the zinc finger transcription factor EGR-1.

Authors:  Ainslie Mitchell; Crispin R Dass; Lun-Quan Sun; Levon M Khachigian
Journal:  Nucleic Acids Res       Date:  2004-06-04       Impact factor: 16.971

10.  Sequence-specific cleavage of hepatitis C virus RNA by DNAzymes: inhibition of viral RNA translation and replication.

Authors:  Swagata Roy; Nidhi Gupta; Nithya Subramanian; Tanmoy Mondal; Akhil Chandra Banerjea; Saumitra Das
Journal:  J Gen Virol       Date:  2008-07       Impact factor: 3.891

View more
  5 in total

1.  Nucleic acids in disease and disorder: Understanding the language of life emerging from the 'ABC' of DNA.

Authors:  Manju Bansal; B Jayaram; Aditya Mittal
Journal:  J Biosci       Date:  2012-07       Impact factor: 1.826

2.  Potent Intracellular Knock-Down of Influenza A Virus M2 Gene Transcript by DNAzymes Considerably Reduces Viral Replication in Host Cells.

Authors:  Binod Kumar; Roopali Rajput; Dibya Ranjan Pati; Madhu Khanna
Journal:  Mol Biotechnol       Date:  2015-09       Impact factor: 2.695

3.  Inhibiting the HIV integration process: past, present, and the future.

Authors:  Roberto Di Santo
Journal:  J Med Chem       Date:  2013-09-25       Impact factor: 7.446

Review 4.  Theranostic DNAzymes.

Authors:  Wenhu Zhou; Jinsong Ding; Juewen Liu
Journal:  Theranostics       Date:  2017-02-23       Impact factor: 11.556

5.  Hepatitis B virus S gene therapy with 10-23 DNAzyme delivered by chitosan-g-stearic acid micelles.

Authors:  Yun Hong; Dongsen Mao; Rui Wu; Zhe Gao; Tingting Meng; Rongrong Wang; Lin Liu; Jing Miao
Journal:  RSC Adv       Date:  2019-05-15       Impact factor: 4.036

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.